Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Ward

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
A double-blind, cross-over, study of oral N-acetylcysteine in Sjögren's syndromeM T Walters, C E Rubin, S J Keightley, et al.
The New England Journal of Medicine|February 23, 1978
[Plasmapheresis for myasthenia gravis]J Newsom-Davis, A Vincent, S G Wilson, et al.
Neurology|July 1, 1983
Parkinson's disease in 65 pairs of twins and in a set of quadrupletsC D Ward, R C Duvoisin, S E Ince, et al.
Clinical Rehabilitation|December 3, 2004
Education for people with progressive neurological conditions can have negative effects: evidence from a randomized controlled trialC D Ward, G Turpin, M E Dewey, et al.
Advances in Neurology|January 1, 1984
Parkinson's disease in twinsC D Ward, R C Duvoisin, S E Ince, et al.
Neurology|January 1, 1982
Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind studyP A LeWitt, G Gopinathan, C D Ward, et al.
Journal of Mammary Gland Biology and Neoplasia|June 8, 2018
cIAP2 Is an Independent Signaling and Survival Factor during Mammary Lactational Involution and TumorigenesisDavid Carr, Rosanna Lau, Alexandra D Hnatykiw, et al.
The Journal of Biological Chemistry|February 15, 1986
The ribosomal binding domain of the Escherichia coli release factors. Modification of tyrosine in the N-terminal domain of ribosomal protein L11 affects release factors 1 and 2 differentiallyW P Tate, K K McCaughan, C D Ward, et al.
Neurology|April 1, 1981
Lisuride in parkinsonismG Gopinathan, H Teräväinen, J M Dambrosia, et al.
Neurology|August 1, 1983
Comparison of pergolide and bromocriptine therapy in parkinsonismP A LeWitt, C D Ward, T A Larsen, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Scandinavian Journal of Rheumatology. Supplement|January 1, 1986
A double-blind, cross-over, study of oral N-acetylcysteine in Sjögren's syndromeM T Walters, C E Rubin, S J Keightley, et al.
The New England Journal of Medicine|February 23, 1978
[Plasmapheresis for myasthenia gravis]J Newsom-Davis, A Vincent, S G Wilson, et al.
Neurology|July 1, 1983
Parkinson's disease in 65 pairs of twins and in a set of quadrupletsC D Ward, R C Duvoisin, S E Ince, et al.
Clinical Rehabilitation|December 3, 2004
Education for people with progressive neurological conditions can have negative effects: evidence from a randomized controlled trialC D Ward, G Turpin, M E Dewey, et al.
Advances in Neurology|January 1, 1984
Parkinson's disease in twinsC D Ward, R C Duvoisin, S E Ince, et al.
Neurology|January 1, 1982
Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind studyP A LeWitt, G Gopinathan, C D Ward, et al.
Journal of Mammary Gland Biology and Neoplasia|June 8, 2018
cIAP2 Is an Independent Signaling and Survival Factor during Mammary Lactational Involution and TumorigenesisDavid Carr, Rosanna Lau, Alexandra D Hnatykiw, et al.
The Journal of Biological Chemistry|February 15, 1986
The ribosomal binding domain of the Escherichia coli release factors. Modification of tyrosine in the N-terminal domain of ribosomal protein L11 affects release factors 1 and 2 differentiallyW P Tate, K K McCaughan, C D Ward, et al.
Neurology|April 1, 1981
Lisuride in parkinsonismG Gopinathan, H Teräväinen, J M Dambrosia, et al.
Neurology|August 1, 1983
Comparison of pergolide and bromocriptine therapy in parkinsonismP A LeWitt, C D Ward, T A Larsen, et al.
Pageof 7